ID

34566

Descripción

A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics; ODM derived from: https://clinicaltrials.gov/show/NCT01685931

Link

https://clinicaltrials.gov/show/NCT01685931

Palabras clave

  1. 19/1/19 19/1/19 -
  2. 31/12/19 31/12/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

19 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Schizophrenia NCT01685931

Eligibility Schizophrenia NCT01685931

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
previous diagnosis of schizophrenia
Descripción

ID.1

Tipo de datos

boolean

experiencing an acute episode, with a positive and negative syndrome scale (panss) total score between 70 and 120, inclusive
Descripción

ID.2

Tipo de datos

boolean

patients currently treated with antipsychotic are allowed to be recruited
Descripción

ID.3

Tipo de datos

boolean

be medically stable on the basis of clinical laboratory tests performed at screening
Descripción

ID.4

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
a primary diagnosis other than schizophrenia
Descripción

ID.5

Tipo de datos

boolean

history of risperidone or paliperidone resistance as defined by failure to respond to 2 adequate treatment periods
Descripción

ID.6

Tipo de datos

boolean

clozapine use for treatment refractory schizophrenia
Descripción

ID.7

Tipo de datos

boolean

relevant history or current presence of any significant or unstable condition, disease or illness that could limit the participation in the study according to the investigator
Descripción

ID.8

Tipo de datos

boolean

woman who is pregnant, breast-feeding, or is planning to become pregnant within 6 months
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Schizophrenia NCT01685931

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
previous diagnosis of schizophrenia
boolean
ID.2
Item
experiencing an acute episode, with a positive and negative syndrome scale (panss) total score between 70 and 120, inclusive
boolean
ID.3
Item
patients currently treated with antipsychotic are allowed to be recruited
boolean
ID.4
Item
be medically stable on the basis of clinical laboratory tests performed at screening
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
a primary diagnosis other than schizophrenia
boolean
ID.6
Item
history of risperidone or paliperidone resistance as defined by failure to respond to 2 adequate treatment periods
boolean
ID.7
Item
clozapine use for treatment refractory schizophrenia
boolean
ID.8
Item
relevant history or current presence of any significant or unstable condition, disease or illness that could limit the participation in the study according to the investigator
boolean
ID.9
Item
woman who is pregnant, breast-feeding, or is planning to become pregnant within 6 months
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial